Hong Kong-listed pharmaceutical stocks saw a partial rebound, with Yaojie Ankang-B (02617.HK) rising nearly 5%, Beihai Kangcheng-B (01228.HK) up 2.7%, and China Antibody-B (03681.HK) and Connoya-B (02162.HK) rising over 2%.
2025-11-05
Hong Kong-listed pharmaceutical stocks saw a partial rebound, with Yaojie Ankang-B (02617.HK) rising nearly 5%, Beihai Kangcheng-B (01228.HK) up 2.7%, and China Antibody-B (03681.HK) and Connoya-B (02162.HK) rising over 2%.